Related Experiment Video
Updated: Jul 14, 2026

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
Published on: March 17, 2023
beta-adrenoceptor agonists downregulate adiponectin, but upregulate adiponectin receptor 2 and tumor necrosis
Ling Fu1, Kazumasa Isobe, Qin Zeng
1Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan.
Abstract:
Recently, the insulin-sensitizing adipokine adiponectin and the insulin resistance-inducing adipokine tumor necrosis factor-alpha (TNF-alpha) were reported to inhibit each other's production in adipocytes. We investigated the effects of two beta(3)-adrenoceptor agonists, 5-[(2R)-2-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL-316,243) and (+/-)-(R(*),R(*))-[4-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]phenoxy]acetic acid (BRL37344), on the gene expression of adiponectin, two adiponectin receptors, and TNF-alpha in adipose tissues of C57BL/6J mice. CL-316,243 and BRL37344 downregulated adiponectin, but upregulated adiponectin receptor 2 (not receptor 1) in epididymal or/and subcutaneous white adipose tissues and in brown adipose tissue. TNF-alpha expression was upregulated only in epididymal adipose tissue. To further explore these effects, we treated differentiated 3T3-L1 adipocytes with the non-selective beta-adrenoceptor agonist isoproterenol. As a result, adiponectin receptor 2 (but not receptor 1) gene expression and TNF-alpha protein expression increased, but gene expression and secretion of adiponectin decreased. The upregulation of adiponectin receptor 2 by isoproterenol is most likely via beta(2),beta(3)-adrenoceptors, adenylyl cyclases, and protein kinase A (PKA). However, the accompanying activation of AMP-activated protein kinase (AMPK) may inhibit this upregulation. Our results suggest that upregulation of TNF-alpha and downregulation of adiponectin by beta-adrenoceptor activation may contribute to the pathogenesis of catecholamine-induced insulin resistance, and that upregulation of adiponectin receptor 2 may be a feedback result of reduced adiponectin.
Insights
Beta-adrenoceptor activation downregulates adiponectin and upregulates TNF-alpha, potentially contributing to insulin resistance. Upregulation of adiponectin receptor 2 may be a feedback response to reduced adiponectin levels.
Area of Science:
- Endocrinology
- Metabolic Research
- Adipose Tissue Biology
Background:
- Adiponectin enhances insulin sensitivity, while TNF-alpha promotes insulin resistance.
- Previous studies suggest mutual inhibition of adiponectin and TNF-alpha production in adipocytes.
- Beta(3)-adrenoceptor agonists are investigated for their metabolic effects.
Purpose of the Study:
- To investigate the effects of beta(3)-adrenoceptor agonists (CL-316,243 and BRL37344) on adiponectin, TNF-alpha, and their receptor gene expression in mouse adipose tissues.
- To explore the impact of beta-adrenoceptor activation on adiponectin and TNF-alpha in 3T3-L1 adipocytes.
Main Methods:
- Administration of beta(3)-adrenoceptor agonists CL-316,243 and BRL37344 to C57BL/6J mice.
- Gene expression analysis of adiponectin, adiponectin receptors (1 and 2), and TNF-alpha in various adipose tissues.
- Treatment of differentiated 3T3-L1 adipocytes with isoproterenol (a non-selective beta-adrenoceptor agonist).
- Measurement of TNF-alpha protein expression and adiponectin secretion in treated adipocytes.
Main Results:
- CL-316,243 and BRL37344 downregulated adiponectin and upregulated adiponectin receptor 2 (not receptor 1) in white and brown adipose tissues.
- TNF-alpha expression was upregulated in epididymal adipose tissue following agonist treatment.
- In 3T3-L1 adipocytes, isoproterenol decreased adiponectin expression/secretion but increased adiponectin receptor 2 and TNF-alpha protein expression.
- Signaling pathways involving adenylyl cyclase, PKA, and AMPK were implicated in the observed effects.
Conclusions:
- Beta-adrenoceptor activation leads to decreased adiponectin and increased TNF-alpha, potentially contributing to catecholamine-induced insulin resistance.
- Upregulation of adiponectin receptor 2 appears to be a compensatory response to reduced adiponectin levels.
- These findings highlight a complex interplay between beta-adrenergic signaling, adipokines, and insulin resistance.
Related Concept Videos
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Receptors (Adrenoceptors): Classification
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
GPCRs Regulate Adenylyl Cylase Activity
Two...
Regulation of Food Intake

